Results 101 to 110 of about 44,621 (163)

Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy. [PDF]

Inflamm Regen
Ito Y, Inoue S, Kagoya Y.
europepmc   +1 more source

FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma. [PDF]

Mol Ther, 2023
Conde E, Casares N, Mancheño U, Elizalde E, Vercher E, Capozzi R, Santamaria E, Rodriguez-Madoz JR, Prosper F, Lasarte JJ, Lozano T, Hervas-Stubbs S.   +11 more
europepmc   +1 more source

A pilot study on the safety and efficacy of neoadjuvant chemo‑adoptive immunotherapy for locally advanced rectal cancer. [PDF]

Oncol Lett
Okazawa Y, Kamigaki T, Sugimoto K, Yamada T, Yoshida Y, Okada S, Ibe H, Oguma E, Iwai T, Matsuda A, Yamada T, Hasegawa S, Goto S, Takimoto R, Sakamoto K.   +14 more
europepmc   +1 more source

Long-term adoptive immunotherapy achieves complete response and bone lesion repair in an elderly patient with macrofocal multiple myeloma. [PDF]

Cancer Pathog Ther
Song Y, Lu X, Wang J, Cai L, Liu T, Wu L, Sun L, Xu X, Gao C, Yang B.   +9 more
europepmc   +1 more source

A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation. [PDF]

PLoS One
Ohira M, Imaoka Y, Sato K, Imaoka K, Bekki T, Yano T, Nakano R, Sakai H, Kuroda S, Tahara H, Ide K, Kobayashi T, Tanaka Y, Tanaka J, Ohdan H.   +14 more
europepmc   +1 more source

Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy. [PDF]

Exp Hematol Oncol
Shao W, Yao Y, Yang L, Li X, Ge T, Zheng Y, Zhu Q, Ge S, Gu X, Jia R, Song X, Zhuang A.   +11 more
europepmc   +1 more source

Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer. [PDF]

J Immunother Cancer
Razmara AM, Farley LE, Harris RM, Judge SJ, Lammers M, Iranpur KR, Johnson EG, Dunai C, Murphy WJ, Brown CT, Rebhun RB, Kent MS, Canter RJ.   +12 more
europepmc   +1 more source

T-cell adoptive immunotherapy for BK nephropathy in renal transplantation. [PDF]

Transpl Infect Dis, 2020
Jahan S, Scuderi C, Francis L, Neller MA, Rehan S, Crooks P, Ambalathingal GR, Smith C, Khanna R, John GT.   +9 more
europepmc   +1 more source

Characterization of atypical T cells generated during ex vivo expansion process for T cell-based adoptive immunotherapy. [PDF]

Front Immunol
Mercier-Letondal P, Kumar A, Marton C, Bonnefoy F, Fredon M, Boullerot L, Dehecq B, Adotévi O, Godet Y, Galaine J.   +9 more
europepmc   +1 more source

Human CD4⁺ iNKT cell adoptive immunotherapy induces anti-tumour responses against CD1d-negative EBV-driven B lymphoma. [PDF]

Immunology
Baiu DC, Sharma A, Schehr JL, Basu J, Smith KA, Ohashi M, Johannsen EC, Kenney SC, Gumperz JE.   +8 more
europepmc   +1 more source